Detalhe da pesquisa
1.
Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial.
Blood
; 141(11): 1265-1276, 2023 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36265087
2.
Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia.
Blood
; 135(5): 371-380, 2020 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31826241
3.
Anticoagulation prophylaxis reduces venous thromboembolism rate in adult acute lymphoblastic leukaemia treated with asparaginase-based therapy.
Br J Haematol
; 191(5): 748-754, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32395867
4.
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.
N Engl J Med
; 377(5): 454-464, 2017 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28644114
5.
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia.
Nature
; 506(7488): 328-33, 2014 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24522528
6.
Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy.
Blood
; 140(3): 285-289, 2022 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35507690
7.
A phase II open-label study of aprepitant as anti-emetic prophylaxis in patients with acute myeloid leukemia (AML) undergoing induction chemotherapy.
Support Care Cancer
; 27(6): 2295-2300, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30341536
8.
Predictive value of molecular remissions postconsolidation chemotherapy in patients with Core Binding Factor Acute Myeloid Leukemia (CBF-AML) - a single center analysis.
Hematol Oncol
; 35(4): 810-813, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27597292
9.
Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy.
Blood
; 124(9): 1426-33, 2014 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25006120
10.
An evaluation of no-treatment decisions in patients with newly diagnosed acute myeloid leukemia.
Am J Hematol
; 96(1): E17-E20, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33021743
11.
A Phase I dose-escalation study of DCLL9718S, an antibody-drug conjugate targeting C-type lectin-like molecule-1 (CLL-1) in patients with acute myeloid leukemia.
Am J Hematol
; 96(5): E175-E179, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33617672
12.
Treatment outcomes following leukemic transformation in Philadelphia-negative myeloproliferative neoplasms.
Blood
; 121(14): 2725-33, 2013 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23361905
13.
Phase II study of targeted therapy with temozolomide in acute myeloid leukaemia and high-risk myelodysplastic syndrome patients pre-screened for low O(6) -methylguanine DNA methyltransferase expression.
Br J Haematol
; 167(5): 664-70, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25160658
14.
Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies.
Am J Hematol
; 89(4): 363-8, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24273151
15.
A pilot phase II RCT of a home-based exercise intervention for survivors of AML.
Support Care Cancer
; 22(4): 881-9, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24240647
16.
Serum voriconazole level variability in patients with hematological malignancies receiving voriconazole therapy.
Can J Infect Dis Med Microbiol
; 25(5): 271-6, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25371690
17.
Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Phase 1b Trial.
Clin Lymphoma Myeloma Leuk
; 2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38378362
18.
Treatment of elderly patients with acute lymphoblastic leukaemia using a paediatric-based protocol.
Br J Haematol
; 163(4): 458-64, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24033272
19.
Ambulatory consolidation chemotherapy for acute myeloid leukemia with antibacterial prophylaxis is associated with frequent bacteremia and the emergence of fluoroquinolone resistant E. Coli.
BMC Infect Dis
; 13: 284, 2013 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-23800256
20.
Changing frontline AML treatment patterns from 2013 to 2022.
Leuk Res
; 132: 107354, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37467567